These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 33570734)

  • 1. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal circ_0007385 enhances non-small cell lung cancer cell proliferation and stemness via regulating miR-1253/FAM83A axis.
    Ning Z; Tian Y; Li Y; Zhao X; Zhang J; Wang C; Hu J; Shen H; Wu W
    Anticancer Drugs; 2022 Jan; 33(1):61-74. PubMed ID: 34620741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.
    Sheng H; Wang X
    Anticancer Drugs; 2023 Feb; 34(2):214-226. PubMed ID: 36730637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis.
    Liu Y; Zhai R; Hu S; Liu J
    Anticancer Drugs; 2022 Jan; 33(1):e186-e197. PubMed ID: 34387608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis.
    Yang C; Shi J; Wang J; Hao D; An J; Jiang J
    Cell Cycle; 2021 Jul; 20(13):1334-1346. PubMed ID: 34189997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis.
    Liu Y; Li C; Liu H; Wang J
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00812. PubMed ID: 34219377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circ_0101675 Promotes NSCLC Cell Proliferation, Migration, Invasion, Angiogenesis and Immune Evasion by Sponging miR-607/PDL1 Axis.
    Lu W; Li L; Li L; Guo N; Ma X
    Biochem Genet; 2024 Jun; 62(3):1539-1555. PubMed ID: 37646893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA SOX13 promotes malignant behavior and cisplatin resistance in non-small cell lung cancer through targeting microRNA-3194-3p/microtubule-associated protein RP/EB family member 1.
    Zhang L; Peng H; Xu Z; Yang Q; Wang Y; Wang H; Bu L
    Bioengineered; 2022 Jan; 13(1):1814-1827. PubMed ID: 34709968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation.
    Chi Y; Luo Q; Song Y; Yang F; Wang Y; Jin M; Zhang D
    J Cell Biochem; 2019 Nov; 120(11):19019-19030. PubMed ID: 31241217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Exosomes-Based Biomarker circ_0008928 Regulates Cisplatin Sensitivity, Tumor Progression, and Glycolysis Metabolism by miR-488/
    Shi Q; Ji T; Ma Z; Tan Q; Liang J
    Cancer Biother Radiopharm; 2023 Oct; 38(8):558-571. PubMed ID: 33661058
    [No Abstract]   [Full Text] [Related]  

  • 11. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression.
    Wan J; Hao L; Zheng X; Li Z
    Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0110498 facilitates the cisplatin resistance of non-small cell lung cancer by mediating the miR-1287-5p/RBBP4 axis.
    Hao D; Li Y; Shi J; Jiang J
    Thorac Cancer; 2023 Mar; 14(7):662-672. PubMed ID: 36691322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).
    Hong W; Xue M; Jiang J; Zhang Y; Gao X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):149. PubMed ID: 32746878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA hsa_circ_0070659 predicts poor prognosis and promotes non-small cell lung cancer (NSCLC) progression via microRNA-377 (miR-377) / Ras-Associated Binding Protein 3C (RAB3C) pathway.
    Meng Q; Li Y; Sun Z; Yang X
    Bioengineered; 2022 Jun; 13(6):14578-14594. PubMed ID: 36694911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0028826 Promotes Growth and Metastasis of NSCLC via Acting as a Sponge of miR-758-3p to Derepress IDH2 Expression.
    Guo L; Liu X; Zhang J; Liu Z; Zhang B; Sun Y; Cui D; Liu J
    Clin Respir J; 2024 Aug; 18(8):e13802. PubMed ID: 39113352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non-small cell lung cancer via positively modulating KPNA4 by sponging miR-1298-5p.
    Hu S; Zhang Q; Sun J; Xue J; Wang C
    Thorac Cancer; 2023 Aug; 14(22):2116-2126. PubMed ID: 37455373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
    Tang YF; Liu ZH; Zhang LY; Shi SH; Xu S; Ma JA; Hu CH; Zou FW
    Mol Cancer; 2024 May; 23(1):91. PubMed ID: 38715012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hsa_circ_0003176 Suppresses the Progression of Non-Small-Cell Lung Cancer via Regulating miR-182-5p/RBM5 Axis.
    Yang F; Pei Y; Xu W; Rong L
    Dis Markers; 2022; 2022():8402116. PubMed ID: 36193508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0091537 promotes gefitinib chemoresistance in non-small cell lung cancer by mediating the miR-520h/YAP1 network.
    Qu R; Ma J
    Anticancer Drugs; 2023 Nov; 34(10):1151-1161. PubMed ID: 36727737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circ_0008450 regulates the proliferation, migration, invasion, apoptosis and chemosensitivity of CDDP-resistant nasopharyngeal carcinoma cells by the miR-338-3p/SMAD5 axis.
    Liu L; Lu B; Li Y
    Anticancer Drugs; 2022 Jan; 33(1):e260-e272. PubMed ID: 34387609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.